OUTLOOK THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
OUTLOOK THERAPEUTICS, INC. (OTLK) had Lessee, Operating Lease, Liability, to be Paid, Year One of $81.82 thousand as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-18
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $81.82K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $81.82K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $81.82K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $80.73K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $81.82K 10-Q · filed 2026-08-18 |
| 2026-03-31 | $81.82K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $81.82K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $80.73K 10-K · filed 2025-12-19 |
| 2025-06-30 | $79.95K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $79.95K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $79.95K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $78.09K 10-K · filed 2024-12-27 |
| 2024-06-30 | $78.09K 10-Q · filed 2024-08-14 |
| 2023-03-31 | $3.95K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $15.81K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $27.68K 10-K · filed 2022-12-29 |
| 2022-06-30 | $27.68K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $27.68K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $27.68K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $46.65K 10-K · filed 2021-12-23 |
| 2021-06-30 | $46.65K 10-Q · filed 2021-08-13 |
| 2020-09-30 | $195.00K 10-K · filed 2020-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |